TABLE 1

LC-MS/MS conditions for compounds investigated and internal standards with details on mass transitions

No.CompoundsInternal StandardElectrospray Ionizationm/zCollision Energy
eV
1BenazeprilFlecainideNegative423.1 > 173.9−28
2CilazaprilFlecainideNegative416.1 > 166.9−28
3QuinaprilFlecainideNegative437.1 > 187.9−30
4TrandolaprilFlecainidePositive431.2 > 234.329
5PerindoprilFlecainidePositive369.2 > 172.327
6RamiprilFlecainideNegative415.1 > 166−34
7TemocaprilFlecainidePositive477.2 > 190.245
8OseltamivirFlecainidePositive313.2 > 165.827
9Candesartan cilexetilFlecainideNegative609.1 > 99−68
10Mycophenolate mofetilFlecainideNegative432.2 > 244.8−44
11Olmesartan medoxomilFlecainideNegative557.1 > 149−62
FlecainideNAPositive415.1 > 39833
NANegative413.2 > 269.9−28
  • NA, not applicable.